Loading...
Loading...
NRX Pharmaceuticals Inc · Pharmaceuticals
Small/Mid Cap
NRX Pharmaceuticals Inc's TraderMatrix Quality Score is 12/100 (Weak), a 0–100 read on profitability, valuation, balance-sheet safety, growth and (for dividend payers) payout safety. NRX Pharmaceuticals Inc is a Pharmaceuticals company in the small/mid cap tier.
NRXP ranks #13 of 14 in the Pharmaceuticals sector by Quality Score. Closest scores:
Quality Score is a 0–100 composite rating blending profitability, valuation, balance-sheet safety, growth and (for dividend payers) payout safety. Higher scores indicate stronger fundamental characteristics. Use it to screen out weak names before selling premium or buying LEAPS. Read the full methodology.
NRX Pharmaceuticals Inc has a TraderMatrix Quality Score of 12/100, which falls in the "Weak" band. It ranks #13 of 14 in the Pharmaceuticals sector. Scores of 80+ are rated High quality, 65–79 Solid, 50–64 Mixed and below 50 Weak. This is a fundamentals read, not investment advice.
The Quality Score is a 0–100 composite that blends profitability, valuation, balance-sheet safety, growth and (for dividend payers) payout safety into one number. NRXP's current score is 12/100.
The score is recalculated as new data arrives. NRXP's score of 12/100 was last updated on Nov 2, 2026.
Updated Nov 2, 2026